Abstract
In an observational study in 19 consecutive acutely hospitalized dialysis patients, ultrafiltration (UF) volume was determined by B‐type natriuretic peptide (BNP) levels. Patients were ultrafiltrated daily until they achieved a target BNP level 2 blood pressure medications decreased from 14 to 6 (Fisher exact test, P=.02). The systolic/diastolic/mean arterial blood pressure decreased from admission to discharge (153.6±43.8/80.6±21.8/102.4±27.3 to 132.1±27.9/68.9±14.6/89.9±16.5 mm Hg; P=.0222/.0139/.0329, respectively). Although all patients were volume‐overloaded at admission according to BNP criteria (>500), only 42% were identified as having heart failure. BNP‐directed UF is safe because it minimizes symptomatic hypotension, identifies occult congestive heart failure in a large number of patients, and significantly reduces blood pressure in addition to reducing body weight and number of medications used.

This publication has 18 references indexed in Scilit: